The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Factors Related to Lipodystrophy and Metabolic Alterations in Patients with Human Immunodeficiency Virus Infection Receiving Highly Active Antiretroviral Therapy
Open accessAbstract
Morphologic and metabolic changes associated with protease inhibitor (PI) therapy have been reported since the introduction of PIs for treatment of human immunodeficiency virus infection. These changes were measured 12-20 months after initiation of PI therapy in a cross-sectional study involving 614 patients from the Antiprotéases Cohorte (APROCO) Study (Agence Nationale de Recherches sur le Sida-EP11). The prevalence was 21% for isolated peripheral atrophy, 17% for isolated fat accumulation, 24% for mixed syndrome, 23% for glucose metabolism alterations, 28% for hypertriglyceridemia (triglyceride level, > or =2.2 mM), and 57% for hypercholesterolemia (cholesterol level, > or =5.5 mM). Age was significantly associated with different phenotypes of lipodystrophy and metabolic alterations, but body-mass index, CD4(+) cell count, and type of nucleoside reverse-transcriptase inhibitor or PI received were not constantly associated with these changes. Furthermore, in all models tested, exposure to stavudine was associated with lipoatrophy and exposure of ritonavir was associated with hypertriglyceridemia. Detection and management of these disorders should be implemented to prevent further complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Surveillance for dracunculiasis, 1981-1991.
Hopkins, D. R., & Ruiz‐Tiben, E. (1992) · PubMed · Cited by 1,110
Brinkman, K., Smeitink, J. A., Romijn, J. A., & Reiss, P. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06102-4 · Cited by 866
Carr, A., Miller, J., Law, M., & Cooper, D. A. (2000) · AIDS · doi:10.1097/00002030-200002180-00001 · Cited by 630
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Périard, D., Telenti, A., Sudre, P., Cheseaux, J.-J., Halfon, P., Reymond, M. J., Marcovina, S. M., Glauser, M. P., Nicod, P., Darioli, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.7.700 · Cited by 605
Saint-Marc, T., Partisani, M., Poizot-Martin, I., Bruno, F., Rouviere, O., Lang, J.-M., Gastaut, J.-A., & Touraine, J.-L. (1999) · AIDS · doi:10.1097/00002030-199909100-00009 · Cited by 581
Walli, R., Herfort, O., Michl, G. M., Demant, T., Jäger, H., Dieterle, C., Bogner, J. R., Landgraf, R., & Goebel, F. D. (1998) · AIDS · doi:10.1097/00002030-199815000-00001 · Cited by 519
Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., Lo, J. C., & Schambelan, M. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00005 · Cited by 518
Mallal, S. A., John, M., Moore, C. B., James, I. R., & McKinnon, E. J. (2000) · AIDS · doi:10.1097/00002030-200007070-00002 · Cited by 510
Tsiodras, S., Mantzoros, C., Hammer, S., & Samore, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2050 · Cited by 452
Hypertriglyceridemia in the acquired immunodeficiency syndrome
Grunfeld, C., Kotler, D. P., Hamadeh, R., Tierney, A., Wang, J., & Pierson, R. N. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90225-8 · Cited by 437
Clinical assessment of HIV-associated lipodystrophy in an ambulatory population
Lichtenstein, K. A., Ward, D. J., Moorman, A. C., Delaney, K. M., Young, B., Palella, F. J., Rhodes, P. H., Wood, K. C., & Holmberg, S. D. (2001) · AIDS · doi:10.1097/00002030-200107270-00008 · Cited by 427
Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
Purnell, J. Q., Zambon, A., Knopp, R. H., Pizzuti, D. J., Achari, R., Leonard, J. M., Locke, C., & Brunzell, J. D. (2000) · AIDS · doi:10.1097/00002030-200001070-00006 · Cited by 387
Garg, A. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00414-3 · Cited by 372
Fat distribution and metabolic changes in patients with HIV infection
Safrin, S., & Grunfeld, C. (1999) · AIDS · doi:10.1097/00002030-199912240-00002 · Cited by 359
Metabolic effects of indinavir in healthy HIV-seronegative men
Noor, M. A., Lo, J. C., Mulligan, K., Schwarz, J.-M., Halvorsen, R. A., Schambelan, M., & Grunfeld, C. (2001) · AIDS · doi:10.1097/00002030-200105040-00001 · Cited by 350
Saint-Marc, T., Partisani, M., Poizot-Martin, I., Rouviere, O., Bruno, F., Avellaneda, R., Lang, J.-M., Gastaut, J.-A., & Touraine, J.-L. (2000) · AIDS · doi:10.1097/00002030-200001070-00005 · Cited by 348
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
Gervasoni, C., Ridolfo, A. L., Trifirò, G., Santambrogio, S., Norbiato, G., Musicco, M., Clerici, M., Galli, M., & Moroni, M. (1999) · Aids · doi:10.1097/00002030-199903110-00004 · Cited by 298
Duran, S., Savès, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P., Salmon, D., Moatti, J.-P., & Leport, C. (2001) · AIDS · doi:10.1097/00002030-200112070-00012 · Cited by 284
Self-citationMayer, K. H., Dube, M. P., Sprecher, D., Henry, W. K., Aberg, J. A., Torriani, F. J., Hodis, H. N., Schouten, J., Levin, J., Myers, G., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/317429 · Cited by 197
Hadigan, C., Miller, K., Corcoran, C., Anderson, E., Basgoz, N., & Grinspoon, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5738 · Cited by 183
van der Valk, M., Gisolf, E. H., Reiss, P., Wit, F. W. N. M., Japour, A., Weverling, G. J., & Danner, S. A. (2001) · AIDS · doi:10.1097/00002030-200105040-00005 · Cited by 175
Thiébaut, R., Daucourt, V., Mercié, P., Ekouévi, D. K., Malvy, D., Morlat, P., Dupon, M., Neau, D., Farbos, S., Marimoutou, C., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/317477 · Cited by 174
Plasma lipids in HIV‐infected patients: a prospective study in 95 patients
CONSTANS, J., PELLEGRIN, J. L., PEUCHANT, E., DUMON, M. F., PELLEGRIN, I., SERGEANT, C., SIMONOFF, M., BROSSARD, G., BARBEAU, P., FLEURY, H., et al. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02185.x · Cited by 172
Vigouroux, C., Gharakhanian, S., Salhi, Y., Nguyen, T. H., Chevenne, D., Capeau, J., & Rozenbaum, W. (1999) · PubMed · Cited by 171
Self-citationInsulin sensitivity and insulin clearance in human immunodeficiency virus-infected men
Hommes, M. J. T., Romijn, J. A., Endert, E., Schattenkerk, J. K. M. E., & Sauerwein, H. P. (1991) · Metabolism · doi:10.1016/0026-0495(91)90059-6 · Cited by 150
Hadigan, C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.1932 · Cited by 139
Dong, K. L., Bausserman, L., Flynn, M. M., Dickinson, B. P., Flanigan, T., Mileno, M. D., Tashima, K. T., & Carpenter, C. C. (1999) · PubMed · Cited by 133
Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease.
Vigouroux, C., Gharakhanian, S., Salhi, Y., Nguyen, T. H., Adda, N., Rozenbaum, W., & Capeau, J. (1999) · PubMed · Cited by 104
Self-citationAntiretroviral therapy-associated hyperlipidaemia in HIV disease
Mooser, V., & Carr, A. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200106000-00011 · Cited by 96
Dubé, M. P., Edmondson‐Melançon, H., Qian, D., Aqeel, R., Johnson, D., & Buchanan, T. A. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200106010-00006 · Cited by 95
Blood lipids of patients with chronic hepatitis: differences related to viral etiology
Fabris, C., Federico, E., Soardo, G., Falleti, E., & Pirisi, M. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)06532-7 · Cited by 88
Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS
Shikuma, C. M., Waslien, C., McKeague, J., Baker, N. K., Arakaki, M., Cui, X. W., Souza, S. A., Imrie, A. A., & Arakaki, R. F. (1999) · AIDS · doi:10.1097/00002030-199907300-00013 · Cited by 43
Petit, J., Duong, M., Duvillard, L., Piroth, L., Grappin, M., Vergès, B. L., Chavanet, P., Brun, J. M., & Portier, H. (2000) · Hormone and Metabolic Research · doi:10.1055/s-2007-978655 · Cited by 42
Bonnet, F., s, M. S., Droz‐Perroteau, C., Peuchant, E., Ch??ne, G., Beylot, J., & Morlat, P. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200010010-00017 · Cited by 34
Atherogen lipid profile in HIV-1-infected patients with lipodystrophy syndrome
Mercié, P., Tchamgoué, S., Thiébaut, R., Viallard, J., Faure, I., Dancourt, V., Marimoutou, C., Dabis, F., Rispal, P., Darmon, Y.-M., et al. (2000) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(00)00103-5 · Cited by 21
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Brown, T. T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1179 · Cited by 851
Saves, M., Chene, G., Ducimetiere, P., Leport, C., Le Moal, G., Amouyel, P., Arveiler, D., Ruidavets, J.-B., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 400
Self-citationValantin, M.-A., Aubron-Olivier, C., Ghosn, J., Laglenne, E., Pauchard, M., Schoen, H., Bousquet, R., Katz, P., Costagliola, D., & Katlama, C. (2003) · AIDS · doi:10.1097/00002030-200311210-00009 · Cited by 355
Fat Distribution in Men With HIV Infection
(2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000182230.47819.aa · Cited by 328
Zeldin, R. K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh029 · Cited by 316
Metadata
- Authors
- Saves, M., Raffi, F., Capeau, J., Rozenbaum, W., Ragnaud, J., Perronne, C., Basdevant, A., Leport, C., Chene, G., & the Antiproteases Cohorte (APROCO) Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-15
- Volume
- 34
- Issue
- 10
- Pages
- 1396-1405
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2150961630
- Cited by
- 254
- References
- 43
- FWCI
- 29.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.